|
Incontinence Quality of Life questionnaire: total score. |
||||||
| I-QOL Total Score |
||||||
|
|
||||||
| Treatment group (N)† |
Time point |
n‡ |
Mean I-QOL |
Mean change in I-QOL from baseline§ |
95% CI for treatment difference in I-QOL |
P |
|
|
||||||
| Placebo (61) |
Baseline |
59 |
61.23 |
|||
| Endpoint |
74.56 |
13.33 |
||||
| Duloxetine (60) |
Baseline |
52 |
62.65 |
|||
| Endpoint |
76.29 |
13.64 |
(-4.77,6.78) |
.732 |
||
|
†N = number randomized. ‡n = number with diary data available for specified analysis. §Baseline is the last nonmissing visit score on or before randomization. ¶95% CI for treatment difference. Abbreviations: CI = confidence interval; I-QOL = Incontinence Quality of Life questionnaire | ||||||
Lin et al. BMC Urology 2008 8:2 doi:10.1186/1471-2490-8-2 |
||||||